<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02612025</url>
  </required_header>
  <id_info>
    <org_study_id>Mucki01</org_study_id>
    <nct_id>NCT02612025</nct_id>
  </id_info>
  <brief_title>Effects of Resistance and Endurance Training in Pediatric Cancer Patients During Intensive Treatment Phase</brief_title>
  <acronym>MUCKI</acronym>
  <official_title>Effects of Combined Resistance and Endurance Training in Pediatric Cancer Patients During Intensive Treatment Phase</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johannes Gutenberg University Mainz</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether combined endurance and resistance training
      can improve muscle strength in children and adolescents with cancer during the intensive
      treatment phase.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle strength: lower limb</measure>
    <time_frame>Six weeks (pre-post intervention)</time_frame>
    <description>Lower limb muscle strength measured by the load (kg) sustained in one repetition maximum test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle strength: upper limb</measure>
    <time_frame>Six weeks (pre-post intervention)</time_frame>
    <description>Upper limb muscle strength measured by the load (kg) sustained in one repetition maximum test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker in Blood</measure>
    <time_frame>At the beginning of the intervention and three and six weeks after the beginning. Comparing the two time points inbetween study groups</time_frame>
    <description>Immune status and metabolic status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Six weeks (pre-post intervention)</time_frame>
    <description>Bioelectrical Impedance Analysis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute-walk performance</measure>
    <time_frame>Six weeks (pre-post intervention)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>six weeks (pre-post intervention)</time_frame>
    <description>Pediatric Quality of Life Inventory (PedsQL) Multidimensional Fatigue Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Six weeks (pre-post intervention)</time_frame>
    <description>KINDL: health related quality of life questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory performance</measure>
    <time_frame>Six weeks (pre-post intervention)</time_frame>
    <description>Ergospirometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pediatric Oncology</condition>
  <arm_group>
    <arm_group_label>Exercise group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise training during intensive medical treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise Training</intervention_name>
    <description>Exercise training during intensive medical treatment. Training mainly composed of endurance and resistance exercises. 3 to 5 times per week for six weeks.</description>
    <arm_group_label>Exercise group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Malignant Tumor

          -  Medical Treatment in the Center for Pediatrics, Hematology, Oncology and
             Hemostaseology Mainz (Germany)

          -  &gt; 3 years

          -  Signed Informed Consent

        Exclusion Criteria:

          -  Functional and/or cognitive limitations which limit performance during training

          -  Orthopedic condition which hinders to adequately participate in exercise training

          -  Heart failure (NYHA III-IV)

          -  Partial or global respiratory failure

          -  Symptomatic coronary disease

          -  Serious therapy-refractory hypertonia

          -  Sustainable thrombocytopenia &lt;10.000/Âµl, f. ex. therapy-refractory autoimmune
             thrombocytopenia

          -  Hereditary or acquired thrombocytopenia or coagulation disturbance

          -  Uncontrolled cerebral spasm

          -  CNS metastases

          -  Medical or psychological condition which does in the doctors opinion not allow
             participation in sport activity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johannes-Gutenberg-University</name>
      <address>
        <city>Mainz</city>
        <state>Rhineland-Palatinate</state>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Stoessel, M.Sc.</last_name>
      <phone>00496131178331</phone>
      <email>mucki@uni-mainz.de</email>
    </contact>
    <investigator>
      <last_name>Joerg Faber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2015</study_first_submitted>
  <study_first_submitted_qc>November 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2015</study_first_posted>
  <last_update_submitted>January 30, 2018</last_update_submitted>
  <last_update_submitted_qc>January 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johannes Gutenberg University Mainz</investigator_affiliation>
    <investigator_full_name>Univ.Prof.Dr.med. Joerg Faber</investigator_full_name>
    <investigator_title>Univ.-Prof. Dr. med.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

